The International Retinal Research Foundation, Inc. – Trademark Portfolio
Entity Type: 99
The International Retinal Research Foundation, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include IRRF and INTERNATIONAL RETINAL RESEARCH FOUNDATION. The owner is based in Birmingham, AL.
Suite 124
1720 University Blvd.
Birmingham, AL 35233
Showing of trademarks Trademarks
Trademark Classifications
The International Retinal Research Foundation, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does The International Retinal Research Foundation, Inc. have?
The International Retinal Research Foundation, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does The International Retinal Research Foundation, Inc. file in?
The International Retinal Research Foundation, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are The International Retinal Research Foundation, Inc.'s most well-known trademarks?
The International Retinal Research Foundation, Inc.'s registered trademark portfolio includes well-known marks such as IRRF and INTERNATIONAL RETINAL RESEARCH FOUNDATION. These are among 2 currently registered trademarks in the portfolio.
What is The International Retinal Research Foundation, Inc.'s trademark registration success rate?
The International Retinal Research Foundation, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.